ELEVANCE HEALTH, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
ELEVANCE HEALTH, INC. (ELV) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$12.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-15.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-15
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$9.00M, a 1000.00% decline year-over-year.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $1.00M.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was $1.00M.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was -$5.00M.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$6.00M.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was -$1.00M.
- ELEVANCE HEALTH, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$14.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$12.00M 10-Q · filed 2026-07-15 | |||
| 2026-03-31 | -$9.00M 10-Q · filed 2026-04-22 | |||
| 2025-12-31 | -$5.00M 10-K · filed 2026-02-06 | |||
| 2025-09-30 | $1.00M 10-Q · filed 2025-10-21 | |||
| 2025-06-30 | $2.00M 10-Q · filed 2026-07-15 | |||
| 2025-03-31 | $1.00M 10-Q · filed 2026-04-22 | |||
| 2024-12-31 | -$6.00M 10-K · filed 2026-02-06 | |||
| 2024-09-30 | $2.00M 10-Q · filed 2025-10-21 | |||
| 2024-06-30 | -$5.00M 10-Q · filed 2025-07-17 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-04-22 | |||
| 2023-12-31 | -$1.00M 10-K · filed 2026-02-06 | |||
| 2023-09-30 | -$2.00M 10-Q · filed 2024-10-17 | |||
| 2023-06-30 | $2.00M 10-Q · filed 2024-07-17 | |||
| 2023-03-31 | $1.00M 10-Q · filed 2024-04-18 | |||
| 2022-12-31 | -$14.00M 10-K · filed 2025-02-20 | |||
| 2022-09-30 | -$16.00M 10-Q · filed 2023-10-18 | |||
| 2022-06-30 | -$10.00M 10-Q/A · filed 2023-09-29 | |||
| 2022-03-31 | -$4.00M 10-Q · filed 2023-04-19 | |||
| 2021-12-31 | -$10.00M 10-K · filed 2024-02-21 | |||
| 2021-09-30 | -$9.00M 10-Q · filed 2022-10-19 | |||
| 2021-06-30 | -$7.00M 10-Q · filed 2022-07-20 | |||
| 2021-03-31 | -$1.00M 10-Q · filed 2022-04-20 | |||
| 2020-12-31 | $7.00M 10-Q · filed 2023-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |